Thus, this review aims to evaluate whether resveratrol treatment could potentially enhance the chemo‐sensitivity of cervical cancer cells to the chemotherapeutic drug, carboplatin, by mitigating the pathological effects of CD44‐induced metastasis and chemoresistance within cervical cancer patients. This evidence concerns the gene CD44 and cervical cancer.